Evidence map›Paper›PMID 35485255›Full record

ArticleBioengineered2022

Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis.

Tingjun Tao, Yan Chen, Bochen Lai, Jinhua Wang, Weiliang Wang, Weimian Xiao, Xushan Cha

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Macrophage Functions in Psoriasis: Lessons from Mouse Models.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Tingjun TaoDepartment of Dermatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Yan ChenDepartment of Dermatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Bochen LaiThe Second Clinical Academy, Xinjiang Medical University, Xinshi District, Urumqi, Xinjiang Uygur Autonomous Region, China.
Jinhua WangDepartment of Dermatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Weiliang WangDepartment of Dermatology, Yangjiang People's Hospital, Yangjiang, Guangdong, China.
Weimian XiaoDepartment of Dermatology, Qingyuan Skin Disease Hospital, Qingyuan, Guangdong, China.
Xushan ChaDepartment of Dermatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Guangzhou University of Chinese Medicine · CNAnhui Medical University · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNQujiang People's Hospital · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate whether shikonin combined with methotrexate could inhibit psoriasis progression by regulating the polarization of macrophages through

Indexed as

MethotrexatePsoriasisAnimalsImiquimodLipopolysaccharidesMacrophagesMiceNaphthoquinonesImiquimodLipopolysaccharidesMethotrexateNaphthoquinonesshikoninmacrophage polarizationmethotrexatepsoriasisShikonin

Identifiers

PMID35485255
PMCPMC9208513
OpenAlexW4225123881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.